X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Clinical & Translational Oncology

期刊標題檢索 CLIN TRANSL ONC 最新評論: Just need confirmation from the corresponding author (2024-05-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Clinical & Translational Oncology]您好,您是該頁面的第 63766 位訪客。

期刊簡介
期刊名稱Clinical & Translational Oncology Clinical & Translational Oncology
LetPub Score
6.5
50 ratings
Rate

Reputation
7.3

Influence
5.0

Speed
9.5

期刊簡稱CLIN TRANSL ONCOL
ISSN1699-048X
E-ISSN1699-3055
h-index42
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.200.8370.790
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2121 / 404
Category: Medicine
Subcategory: Cancer Research
Q2101 / 230

自引率 (2023-2024)3.60%自引率趨勢
掲載範囲
Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
官方網站https://www.springer.com/12094
在線稿件提交https://www.editorialmanager.com/clat/
開放訪問No
出版商Springer International Publishing
主題領域医学
出版國/地區SPAIN
發行頻率月刊
創刊年2000
每年文章數287每年文章數趨勢
黃金OA百分比21.58%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ2157/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1699-048X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2.2 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【Clinical & Translational Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326304
    CANCER RESEARCH310967
    BMC CANCER242833
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197880
    INTERNATIONAL JOURNAL OF CANCER188278
    Asian Pacific Journal of Cancer Prevention184306
    CLINICAL CANCER RESEARCH180958
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171664
    ONCOLOGY REPORTS171248
    CA-A CANCER JOURNAL FOR CLINICIANS163262
  •  

    Clinical & Translational Oncology Clinical & Translational Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Clinical & Translational Oncology] 的評論撰寫評論
作者: Accept Zhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-21 09:41:47 評論於
Just need confirmation from the corresponding author
(0) 讚! | Accept Zhang

作者: 据我文章的期刊都被预警


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2024-05-07 20:23:54 評論於
A Mendel study, assigned on the first day and rejected on the second day. Experience shows that if it is not under review on the first day, it will most likely be rejected
(0) 讚! | 据我文章的期刊都被预警

作者: Zhu Fengfeng


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-01 15:30:07 評論於
How long does it take from submission to review?
(0) 讚! | Zhu Fengfeng

作者: Zhu Fengfeng


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-01 15:12:29 評論於
Do all authors need to operate on the website after submission? It has been a week and the status is still "editor assigned."
(0) 讚! | Zhu Fengfeng

作者: Accept Zhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-24 13:30:59 評論於
2024.04.23 major revisions
(0) 讚! | Accept Zhang

作者: Accept Zhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-04 20:22:33 評論於
Can I ask how long it takes for a non-OA article to be included in WOS?
(0) 讚! | Accept Zhang

作者: Accept Zhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-04 08:58:26 評論於
2024.04.04 reviewers assigned
(0) 讚! | Accept Zhang

作者: Accept Zhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-04 02:12:15 評論於
2024.04.03 new submission
2024.04.03 editor assigned
2024.04.03 Under review
Subsequent updates, record the first submission
(0) 讚! | Accept Zhang

作者: 蠢小葱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-20 03:18:59 評論於
2024.02.19 New Submission
2024.02.20 send back to author
2024.02.20 New Submission
2024.02.23 Reject
(0) 讚! | 蠢小葱

作者: Sueky


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-09-16 19:06:16 評論於
Returning for major repairs for almost two months, it took half a month to revise the manuscript. One day after receiving the response, the notification to prepare for publication was given.
(1) 讚! | Sueky

作者: 汤先生


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2020-11-04 09:33:35 評論於
It was rejected in the first review. They said that my conclusion was not novel. The speed was quite fast, and the result returned within one week.

(7) 讚! | 汤先生

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-05-11 19:50:00 評論於
I submitted two articles. The first review took about a month, requested that I change an experiment, which took two months. After the revised draft was submitted, it was reviewed for another 20 days, overhaul requested and then paper revised for about two months. Submitted again, and after around a week, paper was accepted. The second review took about three months, an overhaul was requested and the article is currently being revised. The journal has a moderate impact score and specializes in oncology. You can try it if you are eager to graduate.

(1) 讚! | 匿名

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-05-06 15:12:00 評論於
Score 1.5 points 1. Science Citation Index Expanded
(0) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Clinical & Translational Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*